HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Treatment of CD33 positive refractory acute lymphoblastic leukemia with Mylotarg.

AuthorsKa-Chun Cheung, Lap-Gate Wong, Yiu-Ming Yeung
JournalLeukemia & lymphoma (Leuk Lymphoma) Vol. 49 Issue 3 Pg. 596-7 (Mar 2008) ISSN: 1029-2403 [Electronic] United States
PMID18297542 (Publication Type: Letter)
Chemical References
  • Aminoglycosides
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antigens, CD
  • Antigens, Differentiation, Myelomonocytic
  • CD33 protein, human
  • Sialic Acid Binding Ig-like Lectin 3
  • Gemtuzumab
Topics
  • Adult
  • Aminoglycosides (therapeutic use)
  • Antibodies, Monoclonal (therapeutic use)
  • Antibodies, Monoclonal, Humanized
  • Antigens, CD
  • Antigens, Differentiation, Myelomonocytic
  • Gemtuzumab
  • Humans
  • Male
  • Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma (drug therapy)
  • Salvage Therapy
  • Sialic Acid Binding Ig-like Lectin 3
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: